Back to funds
View filing
Logos Global Management LP
hedge fundUpdated 27 days agoManaged by Logos Global Management Lp • Latest filing Q2 2026
Portfolio value
$2.3B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
76.8%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $698.7M |
| Q2 2023 | $735.2M |
| Q3 2023 | $749.5M |
| Q4 2023 | $1.1B |
| Q1 2024 | $1.2B |
| Q2 2024 | $1.2B |
| Q3 2024 | $926.8M |
| Q4 2024 | $854.6M |
| Q1 2025 | $562.5M |
| Q2 2025 | $903.8M |
| Q3 2025 | $1.1B |
| Q4 2025 | $1.7B |
| Q1 2026 | $2B |
| Q2 2026 | $2.3B |
Top holdings
68 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EQR ERASCA INC | $222.6M | 12.15M | 9.58% | — |
| 2 | A AAVXF ABIVAX SA | $136.5M | 1.02M | 5.87% | — |
| 3 | R RVMDW REVOLUTION MEDICINES INC | $131.1M | 700.0K | 5.64% | — |
| 4 | I IDYA IDEAYA BIOSCIENCES INC | $111.8M | 3.00M | 4.81% | — |
| 5 | B BNTX BIONTECH SE | $94.4M | 1.01M | 4.07% | — |
| 6 | V VERA VERA THERAPEUTICS INC | $94.4M | 2.20M | 4.06% | — |
| 7 | T TNGX TANGO THERAPEUTICS INC | $89.1M | 2.85M | 3.84% | — |
| 8 | P PRAX PRAXIS PRECISION MEDICINES I | $87M | 260.0K | 3.75% | — |
| 9 | C CLDX CELLDEX THERAPEUTICS INC NEW | $78.1M | 2.10M | 3.36% | — |
| 10 | D DNTH DIANTHUS THERAPEUTICS INC | $78M | 800.0K | 3.36% | — |
| 11 | C CGON CG ONCOLOGY INC | $71M | 1.00M | 3.06% | — |
| 12 | I IRON DISC MEDICINE INC | $64M | 875.0K | 2.75% | — |
| 13 | M MAZE MAZE THERAPEUTICS INC | $57.7M | 1.94M | 2.49% | — |
| 14 | D DYN DYNE THERAPEUTICS INC | $56.6M | 2.55M | 2.44% | — |
| 15 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $52.1M | 2.67M | 2.24% | — |
| 16 | O OCFC OCULAR THERAPEUTIX INC | $52M | 5.30M | 2.24% | — |
| 17 | D DSGN DESIGN THERAPEUTICS INC | $43.4M | 3.00M | 1.87% | — |
| 18 | O OLMA OLEMA PHARMACEUTICALS INC | $40.1M | 3.21M | 1.73% | — |
| 19 | B BLTE BELITE BIO INC | $38.5M | 250.0K | 1.66% | — |
| 20 | A ACHV ACHIEVE LIFE SCIENCE INC | $35.4M | 5.42M | 1.52% | — |